QTTBHealthcareMicro-Cap

Q32 Bio Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Q32 Bio Inc. (QTTB), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are QTTB insiders buying or selling?

Q32 Bio Inc. insiders reported 4 open-market buys ($42.1M) and 81 sells ($109.9M) across 85 Form 4 filings — a net selling position of $67.8M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 2, 2026)

Total Form 4 filings
85
SEC EDGAR
Insider filers
18
Insider buys (4)
$42.1M
Insider sells (81)
$109.9M

Insider sentiment

Net selling

Net insider flow of $67.8M in net selling. 2 insider buys in the last 90 days.

Recent QTTB insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 2, 2026Diyong XuDirector, 10% OwnerPurchase1.9M$8.00$15.0M
Jun 2, 2026ORBIMED ADVISORS LLCDirector, 10% OwnerPurchase1.9M$8.00$15.0M
Feb 28, 2026Lee KalowskiCFO and PresidentSale4.0K$4.51$18.0K
Feb 28, 2026Jodie Pope MorrisonCEOSale9.9K$4.51$44.7K
Feb 28, 2026Shelia M. VioletteChief Scientific OfficerSale2.8K$4.51$12.7K
Dec 5, 2025Jodie Pope MorrisonCEOSale22.5K$3.46$77.9K
Dec 5, 2025Lee KalowskiCFO and PresidentSale9.1K$3.46$31.4K
Aug 28, 2025Jodie Pope MorrisonCEOSale10.5K$1.80$18.9K
Aug 28, 2025Shelia M. VioletteChief Scientific OfficerSale3.0K$1.80$5.4K
Aug 28, 2025Lee KalowskiCFO and PresidentSale4.2K$1.80$7.6K
Aug 14, 2024Arthur TzianabosDirectorSale265$24.20$6.4K
Apr 23, 2024Paul AllowayFormer President and Chief Operating Officer of Homology Medicines, Inc.Sale268$24.21$6.5K
Apr 23, 2024Charles Michaud JrFormer Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc.Sale75$24.20$1.8K
Feb 15, 2024Arthur TzianabosDirectorSale13.0K$0.57$7.4K
Jan 5, 2024Paul AllowayPresident and Chief Operating OfficerSale7.3K$0.57$4.1K
Jan 5, 2024Charles Michaud JrVice President, Corporate Controller and TreasurerSale1.7K$0.57$975.27
Sep 8, 2023Albert SeymourPresident and Chief Executive OfficerSale1.4K$1.15$1.7K
Aug 8, 2023Julie JordanChief Medical OfficerSale1.9K$1.39$2.6K
Aug 4, 2023Julie JordanChief Medical OfficerSale99$1.31$129.69
Mar 6, 2023Paul AllowayChief Legal Officer and SecretarySale11.0K$1.45$15.9K
Jan 11, 2023Michael Lee BlumChief Commercial OfficerSale2.5K$1.39$3.4K
Jan 11, 2023Paul AllowayChief Legal Officer and SecretarySale3.1K$1.39$4.3K
Jan 11, 2023Bradford W SmithChief Financial and Business Officer and TreasurerSale3.7K$1.39$5.2K
Jan 11, 2023Albert SeymourPresident and Chief Executive OfficerSale3.6K$1.39$5.0K
Jan 11, 2023Arthur TzianabosDirectorSale10.6K$1.39$14.8K

Showing the 25 most recent of 85 Form 4 filings for Q32 Bio Inc..

Most active QTTB insiders

  • Albert Seymour12 filings
  • Arthur Tzianabos12 filings
  • Bradford W Smith11 filings
  • Timothy P Kelly11 filings
  • 5AM Ventures IV, L.P.6 filings

Ask anything about QTTB insider activity

Use Trabud's AI agent to query Q32 Bio Inc.'s Form 4 history in plain English — "Show me QTTB CEO purchases this year" or compare it against any other ticker.

Open the AI agent

QTTB insider trading FAQ

Are Q32 Bio Inc. insiders buying or selling?

Across 85 SEC Form 4 filings, Q32 Bio Inc. (QTTB) insiders reported 4 open-market purchases totaling $42.1M and 81 sales totaling $109.9M. That is a net selling position of $67.8M.

How many insiders trade QTTB stock?

18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Q32 Bio Inc.. The most recent filing was accepted on Jun 2, 2026.

Where does Trabud get QTTB insider trading data?

All QTTB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content